Showing 102,161 - 102,180 results of 113,108 for search '(( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 12 m decrease ))', query time: 1.47s Refine Results
  1. 102161

    Self-Assembly of Reactive Linear Cu<sub>3</sub> Building Blocks for Supramolecular Coordination Chemistry and Their Reactivity toward E<sub><i>n</i></sub> Ligand Complexes by Martin Fleischmann (2544508)

    Published 2016
    “…Reactions of <b>2a</b>–<b>c</b> with <i>cyclo</i>-E<sub>5</sub> complexes [Cp*Fe­(η<sup>5</sup>-E<sub>5</sub>)] (E = P (<b>C1</b>), As (<b>C2</b>)) led to the isolation of one-dimensional coordination polymers [Cu<sub>3</sub>(μ-X)<sub>2</sub>(μ-dpmp)<sub>2</sub>(μ,η<sup>1</sup>:η<sup>1</sup>-L)]<sub><i>n</i></sub>[BF<sub>4</sub>]<sub><i>n</i></sub> (<b>8a</b>–<b>b</b>: X = Cl–Br, L = <b>C1</b>; <b>9</b>: X = Cl, L = <b>C2</b>) and symmetrically substituted complex [Cu<sub>3</sub>(μ-I)<sub>2</sub>(μ-dpmp)<sub>2</sub>(η<sup>1</sup>-<b>C1</b>)<sub>2</sub>]<sup>+</sup> (<b>10</b>). …”
  2. 102162

    Image_8_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

    Published 2018
    “…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C<sub>max</sub>, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC<sub>0-Inf</sub>, 222.1 ng/mL h), markedly decreased distribution volume (V<sub>z</sub>, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C<sub>max</sub> (26.6 ng/mL) and AUC<sub>0-Inf</sub> (95.1 ng/mL h), larger V<sub>z</sub> (688.8 L) and CL (22.1 L/h) for VSI. …”
  3. 102163

    Image_1_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

    Published 2018
    “…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C<sub>max</sub>, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC<sub>0-Inf</sub>, 222.1 ng/mL h), markedly decreased distribution volume (V<sub>z</sub>, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C<sub>max</sub> (26.6 ng/mL) and AUC<sub>0-Inf</sub> (95.1 ng/mL h), larger V<sub>z</sub> (688.8 L) and CL (22.1 L/h) for VSI. …”
  4. 102164

    Image_6_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

    Published 2018
    “…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C<sub>max</sub>, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC<sub>0-Inf</sub>, 222.1 ng/mL h), markedly decreased distribution volume (V<sub>z</sub>, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C<sub>max</sub> (26.6 ng/mL) and AUC<sub>0-Inf</sub> (95.1 ng/mL h), larger V<sub>z</sub> (688.8 L) and CL (22.1 L/h) for VSI. …”
  5. 102165

    Image_7_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

    Published 2018
    “…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C<sub>max</sub>, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC<sub>0-Inf</sub>, 222.1 ng/mL h), markedly decreased distribution volume (V<sub>z</sub>, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C<sub>max</sub> (26.6 ng/mL) and AUC<sub>0-Inf</sub> (95.1 ng/mL h), larger V<sub>z</sub> (688.8 L) and CL (22.1 L/h) for VSI. …”
  6. 102166

    Image_3_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

    Published 2018
    “…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C<sub>max</sub>, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC<sub>0-Inf</sub>, 222.1 ng/mL h), markedly decreased distribution volume (V<sub>z</sub>, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C<sub>max</sub> (26.6 ng/mL) and AUC<sub>0-Inf</sub> (95.1 ng/mL h), larger V<sub>z</sub> (688.8 L) and CL (22.1 L/h) for VSI. …”
  7. 102167

    Image_2_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

    Published 2018
    “…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C<sub>max</sub>, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC<sub>0-Inf</sub>, 222.1 ng/mL h), markedly decreased distribution volume (V<sub>z</sub>, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C<sub>max</sub> (26.6 ng/mL) and AUC<sub>0-Inf</sub> (95.1 ng/mL h), larger V<sub>z</sub> (688.8 L) and CL (22.1 L/h) for VSI. …”
  8. 102168

    Image_4_Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphom... by Fen Yang (287005)

    Published 2018
    “…</p><p>Results: In this phase Ia study, a total of eight subjects participated. VCR elimination from the circulation after injection of VSLI was characterized by a significantly increased maximum concentration (C<sub>max</sub>, 86.6 ng/mL) and plasma area under the plasma concentration-time curve from zero to infinity (AUC<sub>0-Inf</sub>, 222.1 ng/mL h), markedly decreased distribution volume (V<sub>z</sub>, 224.1 L) and plasma clearance (CL, 8.9 L/h) compared to lower C<sub>max</sub> (26.6 ng/mL) and AUC<sub>0-Inf</sub> (95.1 ng/mL h), larger V<sub>z</sub> (688.8 L) and CL (22.1 L/h) for VSI. …”
  9. 102169

    TGFβR1 kinase activity is necessary for VE-cadherin expression. by Priya Prahalad (50952)

    Published 2010
    “…Treatment with SB431542 decreases PAI-1 activity, confirming TGFβR1 blockade (b).The samples are as follows: 1 - Control; 2 - RA; 3 - Control, 10 µM SB431542; 4 - RA, 10 µM SB431542; 5 - Control - 50 µM SB431542; 6 - RA, 50 µM SB431542. …”
  10. 102170

    Bursts statistics in the presence of synaptic blockers. by Alberto Mazzoni (54739)

    Published 2013
    “…The black dashed line has a slope of −1.5 in (A) and of −2 in (B), as in the right and left column of <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0000439#pone-0000439-g009" target="_blank">Figure 9</a>, respectively. …”
  11. 102171

    Effect of deferiprone on cell cytotoxicity. by Chhanda Bose (787135)

    Published 2015
    “…Data points represent means ± SD of 3 separate studies. (<b>C) LDH release by PBMC treated with 0.5 mmol of Omniscan and deferiprone together.…”
  12. 102172

    Neuronal response to an external current. by Eduarda Susin (11442545)

    Published 2021
    “…<p>A: External drive fluctuation. External current, in each neuron, varied from 0 to 0.5 nA in a linear way, was kept constant for 500 ms, subsequently decreasing to 0 nA in a linear way. …”
  13. 102173

    Gene body coverage for transcripts longer than 5000 nt. by Benjamín Sigurgeirsson (535869)

    Published 2014
    “…<p>For transcripts longer than 5000<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0091851#pone-0091851-g005" target="_blank">Figure 5</a>. …”
  14. 102174
  15. 102175

    LIS1 modulates cytoplasmic dynein activity in osteoclasts. by Shiqiao Ye (198070)

    Published 2011
    “…(B) Decreased LIS1 expression in osteoclasts causes dispersed Golgi apparatus (arrows in upper panels and inset 1, 3 and 5) and reduced transportation of CLIP170 to the periphery of osteoclasts. …”
  16. 102176

    Identification of common genes between the metal-responsive transcriptome and deletome. by Yong Hwan Jin (44567)

    Published 2008
    “…Genes located in the intersections of the datasets and their ontologies are presented in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000053#pgen.1000053.s007" target="_blank">Table S5</a>.…”
  17. 102177

    Example of data processing for one participant and one task, Grooming. by Ryan R. Bailey (605367)

    Published 2014
    “…Vector magnitudes were smoothed using a 5-sample moving average, resulting in decreased amplitudes. …”
  18. 102178

    datasheet1_Nuciferine Inhibited the Differentiation and Lipid Accumulation of 3T3-L1 Preadipocytes by Regulating the Expression of Lipogenic Genes and Adipokines.docx by Hanyuan Xu (10338752)

    Published 2021
    “…Further mechanism studies showed that 2.5∼20 μM nuciferine significantly decreased FAS promoter activities in 3T3-L1 preadipocytes.…”
  19. 102179

    table1_Nuciferine Inhibited the Differentiation and Lipid Accumulation of 3T3-L1 Preadipocytes by Regulating the Expression of Lipogenic Genes and Adipokines.docx by Hanyuan Xu (10338752)

    Published 2021
    “…Further mechanism studies showed that 2.5∼20 μM nuciferine significantly decreased FAS promoter activities in 3T3-L1 preadipocytes.…”
  20. 102180

    Image1_Nuciferine Inhibited the Differentiation and Lipid Accumulation of 3T3-L1 Preadipocytes by Regulating the Expression of Lipogenic Genes and Adipokines.jpeg by Hanyuan Xu (10338752)

    Published 2021
    “…Further mechanism studies showed that 2.5∼20 μM nuciferine significantly decreased FAS promoter activities in 3T3-L1 preadipocytes.…”